Welcome to the 11th volume of Bioanalysis and we want to take this opportunity to wish you all a Happy New Year. We would like to take this opportunity to reflect on the past 12 months from the perspective of the journal. We want to thank all our authors, readers and reviewers, as well as our esteemed Editorial Board members for their ongoing support.We are very much looking forward to working with everyone in 2019.
Content highlightsBioanalysis continues to publish a wide variety of articles covering key advances within this ever-evolving field and we would like to take this opportunity to reflect on some of our most accessed content of last year, at the time of writing this article (October 2018). One of the most popular articles of this year proved to be the Special Report, ' Immunogenicity of therapeutic protein products: current considerations for anti-drug antibody assay in Japan', which provided the views and recommendations from a Japanese research group on the ADA assay [1].As in 2017, meeting reports feature highly among our most popular content of 2017. One of the most-read articles was the Conference Report from the 11th GCC closed forum [2], the objective of which was for CRO bioanalytical representatives to meet and discuss scientific and regulatory issues specific to bioanalysis. Similarly, 'Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdles' was also one of the most popular conference reports from this year [3].Several editorial-style articles providing a snapshot of issues of topical importance to the bioanalytical community featured in our most read content. Some novel approaches were explored this year, including: ' Machine learning techniques for mass spectrometry imaging data analysis and applications', an Editorial by Zhang and Liu [4], while Devangi Mehta, Shobha Purushothama and Lauren Stevenson explored ' Parallelism: the foundation of biomarker assay development and validation' in their Editorial [5].We have continued to publish a range of exciting research-style articles presenting novel work and representing important advancement in understanding of techniques, which continue to be highly accessed. Examples of these include the Methodology article on the 'Evaluation of cAMS for 14 C microtracer ADME studies: opportunities to change the current drug development paradigm' [6] and a Research Article exploring a 'Novel and rapid LC-MS/MS method for quantitative analysis of methylphenidate in dried blood spots' [7]. A Perspective article exploring the importance of 'Biomarkers in early-phase trials: fundamental issues' [8] was one of the most viewed review-style pieces. These aim to highlight recent significant advances in research, ongoing challenges and unmet needs within the field.As we enter 2019, we will endeavor to continue capturing the trends and evolution of the field of bioanalysis.
